FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs
The FDA approved Pretomanid tablets in combination with bedaquiline and linezolid for treatment of a specific type of highly treatment-resistant tuberculosis of the lungs. Pretomanid in combination with bedaquiline and linezolid is approved for treating adult patients with drug resistant TB. August 14, 2019